Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening

類似資料

• Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
  著者:: Huan Lan, 等
  出版事項: (2020-10-01)
• Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
  著者:: Qiang Xu, 等
  出版事項: (2022-04-01)
• Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
  著者:: Mengying Huang, 等
  出版事項: (2021-05-01)
• Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
  著者:: Ibrahim El-Battrawy, 等
  出版事項: (2022-02-01)
• Between the Beats: Unraveling Diagnostic, Therapeutic Challenges, and Sex Differences in Heart Failure's Gray Zone
  著者:: Nazha Hamdani, 等
  出版事項: (2025-01-01)